Clearmind Medicine Correlations

CMND Stock  USD 1.41  0.01  0.71%   
The correlation of Clearmind Medicine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Clearmind Medicine Correlation With Market

Significant diversification

The correlation between Clearmind Medicine Common and DJI is 0.07 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Clearmind Medicine Common and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clearmind Medicine Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Moving against Clearmind Stock

  0.45AMCCF Amcor plcPairCorr
  0.39HDVTY Henderson InvestmentPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
REVBWINT
WINTQNRX
NBYCOEP
REVBQNRX
CDIOQNRX
REVBNBY
  
High negative correlations   
QNRXCOEP
WINTCOEP
NBYCDIO
REVBCDIO
NBYWINT
NBYQNRX

Risk-Adjusted Indicators

There is a big difference between Clearmind Stock performing well and Clearmind Medicine Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Clearmind Medicine's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
HILS  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
COEP  8.03  2.72  0.27  2.11  7.20 
 22.28 
 92.32 
MGTA  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
QNRX  5.62 (0.82) 0.00  2.06  0.00 
 14.29 
 58.63 
CDIO  10.18  1.74  0.18  1.03  8.69 
 38.46 
 77.44 
WINT  4.94 (1.94) 0.00 (8.96) 0.00 
 12.00 
 32.37 
NBY  3.68  0.01  0.00 (0.06) 5.05 
 6.00 
 26.43 
BXRX  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
REVB  7.01 (1.00) 0.00  0.67  0.00 
 19.81 
 73.67 
BWV  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 

Clearmind Medicine Corporate Management

BCom BCommCFO DirectorProfile
Mylene TouboulAccounting ManagerProfile
Gilad BabchukHead CommunicationProfile
Adi VaronControllerProfile
Pr HadenVice DevelopmentProfile
Pr MSWVice DevelopmentProfile
Adi ZuloffShaniChief OfficerProfile